FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067219 [Registered on: 13/05/2024] Trial Registered Prospectively
Last Modified On: 11/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Role of homoeopathic medicine in migraine  
Scientific Title of Study   SIGNIFICANCE OF MODALITIES FOR SELECTION OF HOMOEOPATHIC SIMILIMUM USING O.E.BOERICKES REPERTORY IN THE TREATMENT OF MIGRAINE-A PROSPECTIVE INTERVENTIONAL STUDY  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pallavi Gupta 
Designation  Postgraduate trainee  
Affiliation  State National Homoeopathic Medical College And Hospital,1-Virajkhand ,Gomtinagar,Lucknow  
Address  Department of Case Taking and Repertory, State National Homoeopathic Medical College And Hospital, 1-Virajkhand, Gomtinagar, Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  08931883661  
Fax    
Email  pallavi.gupta1114@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nutan Sharma  
Designation  Reader  
Affiliation  State National Homoeopathic Medical College And Hospital,1-Virajkhand,Gomtinagar,Lucknow  
Address  Department of Practice of Medicine,State National Homoeopathic Medical College And Hospital,1-Virajkhand, Gomtinagar,Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  08178562292  
Fax    
Email  drnutansharma@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pallavi Gupta 
Designation  Postgraduate trainee  
Affiliation  State National Homoeopathic Medical College And Hospital,1-Virajkhand,Gomtinagar,Lucknow  
Address  Department of Case Taking and Repertory, State National Homoeopathic Medical College And Hospital, 1-Virajkhand, Gomtinagar, Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  08931883661  
Fax    
Email  pallavi.gupta1114@gmail.com  
 
Source of Monetary or Material Support  
State National Homoeopathic Medical College And Hospital, 1-Virajkhand,Gomtinagar Lucknow-226010 
 
Primary Sponsor  
Name  Dr Pallavi Gupta  
Address  Department of Case Taking and Repertory,State National Homoeopathic Medical College And Hospital,1-Virajkhand, Gomtinagar,Lucknow, Uttar Pradesh-226010 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pallavi Gupta   State National Homoeopathic Medical College And Hospital   Opd Number 10,State National Homoeopathic Medical College And Hospital,1-Virajkhand, Gomtinagar,Lucknow, Uttar Pradesh-226010
Lucknow
UTTAR PRADESH 
08931883661

pallavi.gupta1114@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Institutional Ethical Committee of State National Homoeopathic Medical College And Hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G439||Migraine, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized homeopathic medicine   Intervention is planned as administering via oral route individualized homoeopathic medicines to a group of 30 patients suffering from migraine selected with the help of O.E.Boerickes Repertory, in varying potencies of centesimal scale, as per the requirement and direction of Dr.Hahnemann.Each dose shall consist of 4-5 globules of cane sugar medicated with single medicine(preserved in 90%v/v ethanol) to be taken orally on an empty stomach.Dosage and repetition will be done according to the case maintaining homoeopathic principles.The patient will be called for follow up after every 15 days and the final assessment will be done after 6 months.At every follow up after reexamining the case it will be decided whether the patient will receive a dose of individualized homoeopathic medicine or placebo. 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1)Patient giving consent to participate.
2)Having migraine for at least 1 year before treatment OR at least 5 prior attacks.
3)Cases which fulfill the international headache society criteria for migraine. 
 
ExclusionCriteria 
Details  1) Patients with other primary headaches(cluster headache, tension headache)
2) Patients with secondary headache(Trauma, Hypertension)
3) Patients unwilling for inclusion in the study and those who are not able to come for follow up.
4) Patients with systemic illness such as malignancy, neurological, cardiovascular and metabolic condition.
5) Lactating and pregnant mother.
6) Persons with cognitive impairment. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The outcome measurement will be done by assessing the changes in MIDAS and HIT-6 score by considering severity of headache after each follow up in interval of one month gap
upto 6 month. 
4 weeks,24 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
Nil   Nil  
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   24/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Migraine is an episodic neurological disorder that presents as a
throbbing unilateral headache with nausea, phonophobia and photophobia, lasting for
4-72 hours.Migraine is a highly prevalent disorder,affecting 12% of the population, attacking up to 17% of
women and 6% of men yearly.It is the third most prevalent disorder
and seventh specific cause for disability worldwide.This is an open label ,single arm,prospective, interventional study which aims to assess the significance of modalities for selection of homoeopathic similimum using O.E.Boericke’s Repertory in the treatment of migraine.Individualized homoeopathic medicine will be prescribed in centesimal scale after detailed case taking and repertorization with the help of O.E.Boericke’s repertory.MIDAS Score and HIT-6 Score will be calculated every month upto 6 months.The difference between MIDAS score and HIT-6 score before and after treatment will be compared and analyzed.
This study is undertaken to throw light into the significance of 
modalities for selection of homoeopathic similimum in treating the cases of migraine using O.E.Boericke’s Repertory.If the results will be positive, a certain group of remedies can be observed which are frequently indicated in cases of Migraine.There will be also improvement of mental health & behavior of the patient, with overall enhancement in the susceptibility & vitality of the patient.
 
Close